The DOI matches its Crossref record; 172 of the 172 references it cites were found in a registry or an index.
Challenges in glioblastoma research: focus on the tumor microenvironment
Open accessAbstract
Glioblastoma (GBM) is the most deadly type of malignant brain tumor, despite extensive molecular analyses of GBM cells. In recent years, the tumor microenvironment (TME) has been recognized as an important player and therapeutic target in GBM. However, there is a need for a full and integrated understanding of the different cellular and molecular components involved in the GBM TME and their interactions for the development of more efficient therapies. In this review, we provide a comprehensive report of the GBM TME, which assembles the contributions of physicians and translational researchers working on brain tumor pathology and therapy in France. We propose a holistic view of the subject by delineating the specific features of the GBM TME at the cellular, molecular, and therapeutic levels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J. B., Belanger, K., Brandes, A. A., Marosi, C., Bogdahn, U., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043330 · Cited by 21,807
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
The 2021 WHO classification of tumors of the central nervous system: a summary
Louis, D. N., Perry, A., Wesseling, P., Brat, D. J., Cree, I. A., Figarella-Branger, D., Hawkins, C., Ng, H. K., Pfister, S. M., Reifenberger, G., et al. (2021) · Neuro-Oncology · doi:10.1093/neuonc/noab106 · Cited by 12,273
Self-citationSkog, J., Würdinger, T., van Rijn, S., Meijer, D. H., Gainche, L., Curry, W. T., Carter, B. S., Krichevsky, A. M., & Breakefield, X. O. (2008) · Nature Cell Biology · doi:10.1038/ncb1800 · Cited by 5,001
Stupp, R., Taillibert, S., Kanner, A., Read, W., Steinberg, D. M., Lhermitte, B., Toms, S., Idbaih, A., Ahluwalia, M. S., Fink, K., et al. (2017) · JAMA · doi:10.1001/jama.2017.18718 · Cited by 2,644
Self-citationOstrom, Q. T., Cioffi, G., Waite, K., Kruchko, C., & Barnholtz-Sloan, J. S. (2021) · Neuro-Oncology · doi:10.1093/neuonc/noab200 · Cited by 2,529
A Perivascular Niche for Brain Tumor Stem Cells
Calabrese, C., Poppleton, H., Kocak, M., Hogg, T. L., Fuller, C., Hamner, B., Oh, E. Y., Gaber, M. W., Finklestein, D., Allen, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.11.020 · Cited by 2,197
Irradiation and anti–PD-L1 treatment synergistically promote antitumor immunity in mice
Deng, L., Liang, H., Burnette, B., Beckett, M., Darga, T., Weichselbaum, R. R., & Fu, Y.-X. (2014) · Journal of Clinical Investigation · doi:10.1172/jci67313 · Cited by 2,105
The Microenvironmental Landscape of Brain Tumors
Quail, D. F., & Joyce, J. A. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.02.009 · Cited by 1,862
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
Brown, C. E., Alizadeh, D., Starr, R., Weng, L., Wagner, J. R., Naranjo, A., Ostberg, J. R., Blanchard, M. S., Kilpatrick, J., Simpson, J., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1610497 · Cited by 1,836
DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity
Vanpouille-Box, C., Alard, A., Aryankalayil, M. J., Sarfraz, Y., Diamond, J. M., Schneider, R. J., Inghirami, G., Coleman, C. N., Formenti, S. C., & Demaria, S. (2017) · Nature Communications · doi:10.1038/ncomms15618 · Cited by 1,834
O’Rourke, D. M., Nasrallah, M. P., Desai, A., Melenhorst, J. J., Mansfield, K., Morrissette, J. J. D., Martinez-Lage, M., Brem, S., Maloney, E., Shen, A., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa0984 · Cited by 1,803
Reardon, D. A., Brandes, A. A., Omuro, A., Mulholland, P., Lim, M., Wick, A., Baehring, J., Ahluwalia, M. S., Roth, P., Bähr, O., et al. (2020) · JAMA Oncology · doi:10.1001/jamaoncol.2020.1024 · Cited by 1,501
Electrical and synaptic integration of glioma into neural circuits
Venkatesh, H. S., Morishita, W., Geraghty, A. C., Silverbush, D., Gillespie, S. M., Arzt, M., Tam, L. T., Espenel, C., Ponnuswami, A., Ni, L., et al. (2019) · Nature · doi:10.1038/s41586-019-1563-y · Cited by 1,366
Westphal, M., Hilt, D. C., Bortey, E., Delavault, P., Olivares, R., Warnke, P. C., Whittle, I. R., Jääskeläinen, J., & Ram, Z. (2003) · Neuro-Oncology · doi:10.1093/neuonc/5.2.79 · Cited by 1,330
Glutamatergic synaptic input to glioma cells drives brain tumour progression
Venkataramani, V., Tanev, D. I., Strahle, C., Studier-Fischer, A., Fankhauser, L., Kessler, T., Körber, C., Kardorff, M., Ratliff, M., Xie, R., et al. (2019) · Nature · doi:10.1038/s41586-019-1564-x · Cited by 1,197
Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells
Piccirillo, S. G. M., Reynolds, B. A., Zanetti, N., Lamorte, G., Binda, E., Broggi, G., Brem, H., Olivi, A., Dimeco, F., & Vescovi, A. L. (2006) · Nature · doi:10.1038/nature05349 · Cited by 1,176
Weller, M., Butowski, N., Tran, D. D., Recht, L. D., Lim, M., Hirte, H., Ashby, L., Mechtler, L., Goldlust, S. A., Iwamoto, F., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30517-x · Cited by 1,134
Self-citationKlemm, F., Maas, R. R., Bowman, R. L., Kornete, M., Soukup, K., Nassiri, S., Brouland, J.-P., Iacobuzio-Donahue, C. A., Brennan, C., Tabar, V., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.007 · Cited by 1,037
Neuronal Activity Promotes Glioma Growth through Neuroligin-3 Secretion
Venkatesh, H. S., Johung, T. B., Caretti, V., Noll, A., Tang, Y., Nagaraja, S., Gibson, E. M., Mount, C. W., Polepalli, J., Mitra, S. S., et al. (2015) · Cell · doi:10.1016/j.cell.2015.04.012 · Cited by 963
Challenges to curing primary brain tumours
Aldape, K., Brindle, K. M., Chesler, L., Chopra, R., Gajjar, A., Gilbert, M. R., Gottardo, N., Gutmann, D. H., Hargrave, D., Holland, E. C., et al. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0177-5 · Cited by 959
Zhou, W., Ke, S. Q., Huang, Z., Flavahan, W., Fang, X., Paul, J., Wu, L., Sloan, A. E., McLendon, R. E., Li, X., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3090 · Cited by 940
Actively personalized vaccination trial for newly diagnosed glioblastoma
Hilf, N., Kuttruff-Coqui, S., Frenzel, K., Bukur, V., Stevanović, S., Gouttefangeas, C., Platten, M., Tabatabai, G., Dutoit, V., van der Burg, S. H., et al. (2019) · Nature · doi:10.1038/s41586-018-0810-y · Cited by 938
Modelling cancer in microfluidic human organs-on-chips
Sontheimer-Phelps, A., Hassell, B. A., & Ingber, D. E. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-018-0104-6 · Cited by 906
Glioblastoma Stem Cells Generate Vascular Pericytes to Support Vessel Function and Tumor Growth
Cheng, L., Huang, Z., Zhou, W., Wu, Q., Donnola, S., Liu, J. K., Fang, X., Sloan, A. E., Mao, Y., Lathia, J. D., et al. (2013) · Cell · doi:10.1016/j.cell.2013.02.021 · Cited by 905
The movers and shapers in immune privilege of the CNS
Engelhardt, B., Vajkoczy, P., & Weller, R. O. (2017) · Nature Immunology · doi:10.1038/ni.3666 · Cited by 893
Sarkaria, J. N., Hu, L. S., Parney, I. F., Pafundi, D. H., Brinkmann, D. H., Laack, N. N., Giannini, C., Burns, T. C., Kizilbash, S. H., Laramy, J. K., et al. (2018) · Neuro-Oncology · doi:10.1093/neuonc/nox175 · Cited by 746
Glioma cancer stem cells induce immunosuppressive macrophages/microglia
Wu, A., Wei, J., Kong, L.-Y., Wang, Y., Priebe, W., Qiao, W., Sawaya, R., & Heimberger, A. B. (2010) · Neuro-Oncology · doi:10.1093/neuonc/noq082 · Cited by 691
Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors
Chongsathidkiet, P., Jackson, C., Koyama, S., Loebel, F., Cui, X., Farber, S. H., Woroniecka, K., Elsamadicy, A. A., Dechant, C. A., Kemeny, H. R., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0135-2 · Cited by 668
Butowski, N., Colman, H., De Groot, J. F., Omuro, A. M., Nayak, L., Wen, P. Y., Cloughesy, T. F., Marimuthu, A., Haidar, S., Perry, A., et al. (2016) · Neuro-Oncology · doi:10.1093/neuonc/nov245 · Cited by 593
Herrlinger, U., Tzaridis, T., Mack, F., Steinbach, J. P., Schlegel, U., Sabel, M., Hau, P., Kortmann, R.-D., Krex, D., Grauer, O., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(18)31791-4 · Cited by 568
Liau, L. M., Ashkan, K., Tran, D. D., Campian, J. L., Trusheim, J. E., Cobbs, C. S., Heth, J. A., Salacz, M., Taylor, S., D’Andre, S. D., et al. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1507-6 · Cited by 537
VEGF-C-driven lymphatic drainage enables immunosurveillance of brain tumours
Song, E., Mao, T., Dong, H., Boisserand, L. S. B., Antila, S., Bosenberg, M., Alitalo, K., Thomas, J.-L., & Iwasaki, A. (2020) · Nature · doi:10.1038/s41586-019-1912-x · Cited by 532
Normalizing Function of Tumor Vessels: Progress, Opportunities, and Challenges
Martin, J. D., Seano, G., & Jain, R. K. (2019) · Annual Review of Physiology · doi:10.1146/annurev-physiol-020518-114700 · Cited by 530
Self-citationLaske, D. W., Youle, R. J., & Oldfield, E. H. (1997) · Nature Medicine · doi:10.1038/nm1297-1362 · Cited by 525
Grossman, S. A., Ye, X., Piantadosi, S., Desideri, S., Nabors, L. B., Rosenfeld, M., Fisher, J., & for the NABTT CNS Consortium (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-3106 · Cited by 448
Gameiro, S. R., Jammeh, M. L., Wattenberg, M. M., Tsang, K. Y., Ferrone, S., & Hodge, J. W. (2014) · Oncotarget · doi:10.18632/oncotarget.1719 · Cited by 415
Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysis
Mathewson, N. D., Ashenberg, O., Tirosh, I., Gritsch, S., Perez, E. M., Marx, S., Jerby-Arnon, L., Chanoch-Myers, R., Hara, T., Richman, A. R., et al. (2021) · Cell · doi:10.1016/j.cell.2021.01.022 · Cited by 408
Fate mapping of human glioblastoma reveals an invariant stem cell hierarchy
Lan, X., Jörg, D. J., Cavalli, F. M. G., Richards, L. M., Nguyen, L. V., Vanner, R. J., Guilhamon, P., Lee, L., Kushida, M. M., Pellacani, D., et al. (2017) · Nature · doi:10.1038/nature23666 · Cited by 405
Lombardi, G., De Salvo, G. L., Brandes, A. A., Eoli, M., Rudà, R., Faedi, M., Lolli, I., Pace, A., Daniele, B., Pasqualetti, F., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30675-2 · Cited by 397
Wei, J., Marisetty, A., Schrand, B., Gabrusiewicz, K., Hashimoto, Y., Ott, M., Grami, Z., Kong, L.-Y., Ling, X., Caruso, H., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci121266 · Cited by 396
Evolving Drug Delivery Strategies to Overcome the Blood Brain Barrier
S. Hersh, D., S. Wadajkar, A., B. Roberts, N., G. Perez, J., P. Connolly, N., Frenkel, V., A. Winkles, J., F. Woodworth, G., & J. Kim, A. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666151221150733 · Cited by 387
Miroshnikova, Y. A., Mouw, J. K., Barnes, J. M., Pickup, M. W., Lakins, J. N., Kim, Y., Lobo, K., Persson, A. I., Reis, G. F., McKnight, T. R., et al. (2016) · Nature Cell Biology · doi:10.1038/ncb3429 · Cited by 383
Tumor Purity as an Underlying Key Factor in Glioma
Zhang, C., Cheng, W., Ren, X., Wang, Z., Liu, X., Li, G., Han, S., Jiang, T., & Wu, A. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2598 · Cited by 383
A new alternative mechanism in glioblastoma vascularization: tubular vasculogenic mimicry
El Hallani, S., Boisselier, B., Peglion, F., Rousseau, A., Colin, C., Idbaih, A., Marie, Y., Mokhtari, K., Thomas, J. L., Eichmann, A., et al. (2010) · Brain · doi:10.1093/brain/awq044 · Cited by 374
Self-citationSamson, A., Scott, K. J., Taggart, D., West, E. J., Wilson, E., Nuovo, G. J., Thomson, S., Corns, R., Mathew, R. K., Fuller, M. J., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aam7577 · Cited by 373
NK Cells Recognize and Kill Human Glioblastoma Cells with Stem Cell-Like Properties
Castriconi, R., Daga, A., Dondero, A., Zona, G., Poliani, P. L., Melotti, A., Griffero, F., Marubbi, D., Spaziante, R., Bellora, F., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802845 · Cited by 337
Robert, S. M., Buckingham, S. C., Campbell, S. L., Robel, S., Holt, K. T., Ogunrinu-Babarinde, T., Warren, P. P., White, D. M., Reid, M. A., Eschbacher, J. M., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa8103 · Cited by 301
Induction of autophagy is essential for monocyte-macrophage differentiation
Zhang, Y., Morgan, M. J., Chen, K., Choksi, S., & Liu, Z.-G. (2012) · Blood · doi:10.1182/blood-2011-08-372383 · Cited by 291
Glioblastoma stem‐like cells secrete the pro‐angiogenic VEGF‐A factor in extracellular vesicles
Treps, L., Perret, R., Edmond, S., Ricard, D., & Gavard, J. (2017) · Journal of Extracellular Vesicles · doi:10.1080/20013078.2017.1359479 · Cited by 277
Self-citationDas, S., & Marsden, P. A. (2013) · New England Journal of Medicine · doi:10.1056/nejmcibr1309402 · Cited by 268
Johnson, K. C., Anderson, K. J., Courtois, E. T., Gujar, A. D., Barthel, F. P., Varn, F. S., Luo, D., Seignon, M., Yi, E., Kim, H., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00926-8 · Cited by 265
Chaperone-Mediated Autophagy Is Required for Tumor Growth
Kon, M., Kiffin, R., Koga, H., Chapochnick, J., Macian, F., Varticovski, L., & Cuervo, A. M. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3003182 · Cited by 261
Griveau, A., Seano, G., Shelton, S. J., Kupp, R., Jahangiri, A., Obernier, K., Krishnan, S., Lindberg, O. R., Yuen, T. J., Tien, A.-C., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.020 · Cited by 261
Self-citationGeletneky, K., Hajda, J., Angelova, A. L., Leuchs, B., Capper, D., Bartsch, A. J., Neumann, J.-O., Schöning, T., Hüsing, J., Beelte, B., et al. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.08.016 · Cited by 260
Chaperone-mediated Autophagy Targets Hypoxia-inducible Factor-1α (HIF-1α) for Lysosomal Degradation
Hubbi, M. E., Hu, H., Kshitiz, Ahmed, I., Levchenko, A., & Semenza, G. L. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.414771 · Cited by 242
Glioma infiltration and extracellular matrix: key players and modulators
Ferrer, V. P., Moura Neto, V., & Mentlein, R. (2018) · Glia · doi:10.1002/glia.23309 · Cited by 222
Drogat, B., Auguste, P., Nguyen, D. T., Bouchecareilh, M., Pineau, R., Nalbantoglu, J., Kaufman, R. J., Chevet, E., Bikfalvi, A., & Moenner, M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3235 · Cited by 220
Self-citationDolma, S., Selvadurai, H. J., Lan, X., Lee, L., Kushida, M., Voisin, V., Whetstone, H., So, M., Aviv, T., Park, N., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.05.002 · Cited by 214
Antonios, J. P., Soto, H., Everson, R. G., Moughon, D., Orpilla, J. R., Shin, N. P., Sedighim, S., Treger, J., Odesa, S., Tucker, A., et al. (2017) · Neuro-Oncology · doi:10.1093/neuonc/now287 · Cited by 206
Seano, G., Nia, H. T., Emblem, K. E., Datta, M., Ren, J., Krishnan, S., Kloepper, J., Pinho, M. C., Ho, W. W., Ghosh, M., et al. (2019) · Nature Biomedical Engineering · doi:10.1038/s41551-018-0334-7 · Cited by 201
Self-citationMICA/NKG2D-mediated immunogene therapy of experimental gliomas.
Friese, M. A., Platten, M., Lutz, S. Z., Naumann, U., Aulwurm, S., Bischof, F., Bühring, H. ‐., DICHGANS, J., Rammensee, H., Steinle, A., et al. (2003) · PubMed · Cited by 193
The roles of glucose metabolic reprogramming in chemo- and radio-resistance
Lin, J., Xia, L., Liang, J., Han, Y., Wang, H., Oyang, L., Tan, S., Tian, Y., Rao, S., Chen, X., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1214-z · Cited by 189
Extracellular nucleosides and nucleotides as immunomodulators
Kepp, O., Loos, F., Liu, P., & Kroemer, G. (2017) · Immunological Reviews · doi:10.1111/imr.12571 · Cited by 188
Marcus, H. J., Carpenter, K. L. H., Price, S. J., & Hutchinson, P. J. (2010) · Journal of Neuro-Oncology · doi:10.1007/s11060-009-9990-5 · Cited by 186
Infiltrative and drug‐resistant slow‐cycling cells support metabolic heterogeneity in glioblastoma
Hoang‐Minh, L. B., Siebzehnrubl, F. A., Yang, C., Suzuki‐Hatano, S., Dajac, K., Loche, T., Andrews, N., Schmoll Massari, M., Patel, J., Amin, K., et al. (2018) · The EMBO Journal · doi:10.15252/embj.201798772 · Cited by 185
CD8+ T-cell infiltrate in newly diagnosed glioblastoma is associated with long-term survival
Yang, I., Tihan, T., Han, S. J., Wrensch, M. R., Wiencke, J., Sughrue, M. E., & Parsa, A. T. (2010) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2010.03.031 · Cited by 181
Fareh, M., Turchi, L., Virolle, V, Debruyne, D., Almairac, F., de-la-Forest Divonne, S., Paquis, P., Preynat-Seauve, O., Krause, K.-H., Chneiweiss, H., et al. (2012) · Cell Death & Differentiation · doi:10.1038/cdd.2011.89 · Cited by 180
Self-citationDual IRE 1 RN ase functions dictate glioblastoma development
Lhomond, S., Avril, T., Dejeans, N., Voutetakis, K., Doultsinos, D., McMahon, M., Pineau, R., Obacz, J., Papadodima, O., Jouan, F., et al. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201707929 · Cited by 174
Self-citationPinto, G., Saenz-de-Santa-Maria, I., Chastagner, P., Perthame, E., Delmas, C., Toulas, C., Moyal-Jonathan-Cohen, E., Brou, C., & Zurzolo, C. (2021) · Biochemical Journal · doi:10.1042/bcj20200710 · Cited by 173
Perrin, S. L., Samuel, M. S., Koszyca, B., Brown, M. P., Ebert, L. M., Oksdath, M., & Gomez, G. A. (2019) · Biochemical Society Transactions · doi:10.1042/bst20180444 · Cited by 171
Structure and Junctional Complexes of Endothelial, Epithelial and Glial Brain Barriers
Dias, M. C., Mapunda, J. A., Vladymyrov, M., & Engelhardt, B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215372 · Cited by 170
Autophagy Is Required for Neutrophil-Mediated Inflammation
Bhattacharya, A., Wei, Q., Shin, J. N., Abdel Fattah, E., Bonilla, D. L., Xiang, Q., & Eissa, N. T. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.08.019 · Cited by 169
Convection-enhanced drug delivery for glioblastoma: a review
D’Amico, R. S., Aghi, M. K., Vogelbaum, M. A., & Bruce, J. N. (2021) · Journal of Neuro-Oncology · doi:10.1007/s11060-020-03408-9 · Cited by 168
Glioblastoma Behaviors in Three-Dimensional Collagen-Hyaluronan Composite Hydrogels
Rao, S. S., DeJesus, J., Short, A. R., Otero, J. J., Sarkar, A., & Winter, J. O. (2013) · ACS Applied Materials & Interfaces · doi:10.1021/am402097j · Cited by 167
GABA’s Control of Stem and Cancer Cell Proliferation in Adult Neural and Peripheral Niches
Young, S. Z., & Bordey, A. (2009) · Physiology · doi:10.1152/physiol.00002.2009 · Cited by 165
Re-Education of Macrophages as a Therapeutic Strategy in Cancer
Kowal, J., Kornete, M., & Joyce, J. A. (2019) · Immunotherapy · doi:10.2217/imt-2018-0156 · Cited by 161
Xie, Y., He, L., Lugano, R., Zhang, Y., Cao, H., He, Q., Chao, M., Liu, B., Cao, Q., Wang, J., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.150861 · Cited by 160
RhoA/ROCK signaling is critical to FAK activation by cyclic stretch in cardiac myocytes
Torsoni, A. S., Marin, T. M., Velloso, L. A., & Franchini, K. G. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00692.2004 · Cited by 155
Chloride Accumulation Drives Volume Dynamics Underlying Cell Proliferation and Migration
Habela, C. W., Ernest, N. J., Swindall, A. F., & Sontheimer, H. W. (2008) · Journal of Neurophysiology · doi:10.1152/jn.90840.2008 · Cited by 154
Influence of the Tumor Microenvironment on Cancer Cells Metabolic Reprogramming
Gouirand, V., Guillaumond, F., & Vasseur, S. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00117 · Cited by 154
Cloughesy, T. F., Finocchiaro, G., Belda-Iniesta, C., Recht, L. D., Brandes, A. A., Pineda, E., Mikkelsen, T., Chinot, O. L., Balañá, C., Macdonald, D. R., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2015.64.7685 · Cited by 150
Truong, D., Fiorelli, R., Barrientos, E. S., Melendez, E. L., Sanai, N., Mehta, S., & Nikkhah, M. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2018.07.048 · Cited by 150
Nicotinamide metabolism regulates glioblastoma stem cell maintenance
Jung, J., Kim, L. J. Y., Wang, X., Wu, Q., Sanvoranart, T., Hubert, C. G., Prager, B. C., Wallace, L. C., Jin, X., Mack, S. C., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.90019 · Cited by 149
Obacz, J., Avril, T., Reste, P. L., Urra, H., Quillien, V., Hetz, C. A., & Chevet, É. (2017) · Science Signaling · doi:10.1126/scisignal.aal2323 · Cited by 147
Self-citationEndothelium-Microenvironment Interactions in the Developing Embryo and in the Adult
Red‐Horse, K., Crawford, Y., Shojaei, F., & Ferrara, N. (2007) · Developmental Cell · doi:10.1016/j.devcel.2007.01.013 · Cited by 143
Role of Microenvironment in Glioma Invasion: What We Learned from In Vitro Models
Manini, I., Caponnetto, F., Bartolini, A., Ius, T., Mariuzzi, L., Loreto, C. D., Beltrami, A. P., & Cesselli, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010147 · Cited by 137
Immunocytokines are a promising immunotherapeutic approach against glioblastoma
Weiss, T., Puca, E., Silginer, M., Hemmerle, T., Pazahr, S., Bink, A., Weller, M., Neri, D., & Roth, P. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.abb2311 · Cited by 133
Secretome Signature of Invasive Glioblastoma Multiforme
Formolo, C. A., Williams, R., Gordish‐Dressman, H., MacDonald, T. J., Lee, N. H., & Hathout, Y. (2011) · Journal of Proteome Research · doi:10.1021/pr200210w · Cited by 133
Blood-brain barrier, cytotoxic chemotherapies and glioblastoma
Dréan, A., Goldwirt, L., Verreault, M., Canney, M. S., Schmitt, C., Guehennec, J., Delattre, J., Carpentier, A. C., & Idbaïh, A. (2016) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2016.1202761 · Cited by 130
Self-citationChromatin Regulator PRC2 Is a Key Regulator of Epigenetic Plasticity in Glioblastoma
Natsume, A., Ito, M., Katsushima, K., Ohka, F., Hatanaka, A., Shinjo, K., Sato, S., Takahashi, S., Ishikawa, Y., Takeuchi, I., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0109 · Cited by 129
Huang, M., Liu, T., Ma, P., Mitteer, R. A., Zhang, Z., Kim, H. J., Yeo, E., Zhang, D., Cai, P., Li, C., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci84876 · Cited by 128
Hubbi, M. E., Gilkes, D. M., Hu, H., Gupta, K., Ahmed, I., & Semenza, G. L. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1412840111 · Cited by 125
Wen, P. Y., Drappatz, J., de Groot, J., Prados, M. D., Reardon, D. A., Schiff, D., Chamberlain, M. C., Mikkelsen, T., Desjardins, A., Holland, J. S., et al. (2017) · Neuro-Oncology · doi:10.1093/neuonc/nox154 · Cited by 125
CXCL12 mediates glioblastoma resistance to radiotherapy in the subventricular zone
Goffart, N., Lombard, A., Lallemand, F., Kroonen, J., Nassen, J., Valentin, E. D., Berendsen, S., Dedobbeleer, M., Willems, E., Robe, P. A. J. T., et al. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now136 · Cited by 120
Encapsulated Stem Cells Loaded With Hyaluronidase-expressing Oncolytic Virus for Brain Tumor Therapy
Martínez‐Quintanilla, J., He, D., Wakimoto, H., Alemany, R., & Shah, K. (2014) · Molecular Therapy · doi:10.1038/mt.2014.204 · Cited by 118
Nuclear p53-mediated repression of autophagy involves PINK1 transcriptional down-regulation
Goiran, T., Duplan, E., Rouland, L., Manaa, W. E., Lauritzen, I., Dunys, J., You, H., Checler, F., & da Costa, C. A. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-017-0016-0 · Cited by 114
Fabbro-Péray, P., Zouaoui, S., Darlix, A., Fabbro, M., Pallud, J., Rigau, V., Mathieu‐Daudé, H., Bessaoud, F., Bauchet, F., Riondel, A., et al. (2018) · Journal of Neuro-Oncology · doi:10.1007/s11060-018-03065-z · Cited by 114
Self-citationThomas, R. P., Nagpal, S., Iv, M., Soltys, S. G., Bertrand, S., Pelpola, J. S., Ball, R. L., Yang, J., H, V. S. M. P., Chernikova, S. B., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-1421 · Cited by 114
Sahebjam, S., Forsyth, P. A., Tran, N., Arrington, J. A., Macaulay, R. J. B., Etame, A. B., Walko, C. M., Boyle, T. A., Peguero, E. N., Jaglal, M. V., et al. (2020) · Neuro-Oncology · doi:10.1093/neuonc/noaa260 · Cited by 114
The ATF6 pathway of the ER stress response contributes to enhanced viability in glioblastoma
Dadey, D. Y. A., Kapoor, V., Khudanyan, A., Urano, F., Kim, A. H., Thotala, D. K., & Hallahan, D. E. (2015) · Oncotarget · doi:10.18632/oncotarget.6712 · Cited by 112
Valdor, R., García‐Bernal, D., Riquelme, D., Martínez, C. M., Moraleda, J. M., Cuervo, A. M., Macián, F., & Martínez, S. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1903542116 · Cited by 112
Modification of Extracellular Matrix Enhances Oncolytic Adenovirus Immunotherapy in Glioblastoma
Kiyokawa, J., Kawamura, Y., Ghouse, S. M., Acar, S., Barçın, E., Martínez‐Quintanilla, J., Martuza, R. L., Alemany, R., Rabkin, S. D., Shah, K., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-2400 · Cited by 110
Chen, J.-W. E., Pedrón, S., & Harley, B. A. C. (2017) · Macromolecular Bioscience · doi:10.1002/mabi.201700018 · Cited by 109
Efficient Mitochondrial Glutamine Targeting Prevails Over Glioblastoma Metabolic Plasticity
Oizel, K., Chauvin, C., Oliver, L., Gratas, C., Geraldo, F., Jarry, U., Scotet, E., Rabé, M., Alves‐Guerra, M., Teusan, R., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-3102 · Cited by 109
Self-citationPeñaranda-Fajardo, N. M., Meijer, C., Liang, Y., Dijkstra, B. M., Aguirre‐Gamboa, R., den Dunnen, W. F. A., & Kruyt, F. A. E. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1934-1 · Cited by 107
Microenvironmental Heterogeneity in Brain Malignancies
Perus, L. J. M., & Walsh, L. A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02294 · Cited by 106
Ozturk, M. S., Lee, V. K., Zou, H., Friedel, R. H., Dai, G., & Intes, X. (2020) · Science Advances · doi:10.1126/sciadv.aay7513 · Cited by 105
Huang, J.-Y., Cheng, Y.-J., Lin, Y.-P., Lin, H.-C., Su, C.-C., Juliano, R. L., & Yang, B.-C. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0901352 · Cited by 103
Ivković, S., Beadle, C., Noticewala, S. S., Massey, S. C., Swanson, K. R., Toro, L. N., Bresnick, A. R., Canoll, P., & Rosenfeld, S. S. (2012) · Molecular Biology of the Cell · doi:10.1091/mbc.e11-01-0039 · Cited by 103
Fujita, M., Scheurer, M. E., Decker, S. A., McDonald, H. A., Kohanbash, G., Kastenhuber, E. R., Kato, H., Bondy, M. L., Ohlfest, J. R., & Okada, H. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0644 · Cited by 103
Khan, S., Mittal, S., McGee, K., Alfaro-Munoz, K. D., Majd, N., Balasubramaniyan, V., & de Groot, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21061954 · Cited by 99
de Groot, J. D., Liu, T.-J., Fuller, G., & Yung, W. K. A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3626 · Cited by 97
Jumping the barrier: VE‐cadherin, VEGF and other angiogenic modifiers in cancer
Le Guelte, A., Dwyer, J., & Gavard, J. (2011) · Biology of the Cell · doi:10.1042/bc20110069 · Cited by 91
Self-citationControl of glioma cell death and differentiation by PKM2–Oct4 interaction
Morfouace, M., Lalier-Bretaudeau, L., Oliver, L., Cheray, M., Pecqueur, C., Cartron, P., & Vallette, F. M. (2014) · Cell Death and Disease · doi:10.1038/cddis.2013.561 · Cited by 91
Self-citationReste, P. L., Pineau, R., Voutetakis, K., Samal, J., Jégou, G., Lhomond, S., Gorman, A. M., Samali, A., Patterson, J. B., Zeng, Q., et al. (2019) · Cancer Letters · doi:10.1016/j.canlet.2020.08.028 · Cited by 89
Self-citationCancer immunoediting in malignant glioma.
Dunn, G., Fecci, P., & Curry, W. (2012) · Neurosurgery · doi:10.1227/neu.0b013e31824f840d · Cited by 86
Phase 2 study of temozolomide and Caelyx in patients with recurrent glioblastoma multiforme
Chua, S. L. L., Rosenthal, M. A., Wong, S., Ashley, D. M., Woods, A.-M., DOWLING, A. J., & Cher, L. (2004) · Neuro-Oncology · doi:10.1215/s1152851703000188 · Cited by 85
Shahar, T., Rozovski, U., Hess, K. R., Hossain, A., Gumin, J., Gao, F., Fuller, G. N., Goodman, L. D., Sulman, E. P., & Lang, F. F. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now239 · Cited by 85
The scrambled story between hyaluronan and glioblastoma
Pibuel, M. A., Poodts, D., Díaz, M., Hajos, S. E., & Lompardía, S. L. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100549 · Cited by 83
Immune phenotypes predict survival in patients with glioblastoma multiforme
Mostafa, H., Paľa, A., Högel, J., Hlaváč, M., Dietrich, E., Westhoff, M., Nonnenmacher, L., Burster, T., Georgieff, M., Wirtz, C. R., et al. (2016) · Journal of Hematology & Oncology · doi:10.1186/s13045-016-0272-3 · Cited by 81
El-Habr, E. A., Dubois, L. G., Burel‐Vandenbos, F., Bogeas, A., Lipecka, J., Turchi, L., Lejeune, F., Coehlo, P. L. C., Yamaki, T., Wittmann, B. M., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1659-5 · Cited by 81
Self-citationTumor-penetrating peptide for systemic targeting of Tenascin-C
Lingasamy, P., Tobi, A., Kurm, K., Kopanchuk, S., Sudakov, A., Salumäe, M., Rätsep, T., Asser, T., Bjerkvig, R., & Teesalu, T. (2020) · Scientific Reports · doi:10.1038/s41598-020-62760-y · Cited by 79
Identification of a Druggable Pathway Controlling Glioblastoma Invasiveness
Pencheva, N., de Gooijer, M. C., Vis, D. J., Wessels, L. F. A., Würdinger, T., van Tellingen, O., & Bernards, R. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.06.036 · Cited by 77
Smits, A., Jin, Z., Elsir, T., Pedder, H., Nistér, M., Alafuzoff, I. I., Dimberg, A., Edqvist, P.-H. D., Pontén, F., Aronica, E., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037041 · Cited by 75
Recapitulating the vasculature using ORGAN-ON-CHIP technology
Pollet, A. M. A. O., & den Toonder, J. M. J. (2020) · Bioengineering · doi:10.3390/bioengineering7010017 · Cited by 73
Hajji, N., García‐Revilla, J., Soto, M. S., Perryman, R., Symington, J. J., Quarles, C. C., Healey, D. R., Guo, Y., Orta, M. L., Mateos-Cordero, S., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci142137 · Cited by 73
Simon, T. R., Pinioti, S., Schellenberger, P., Rajeeve, V., Wendler, F., Cutillas, P. R., King, A. A. K., Stebbing, J., & Giamas, G. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0878-x · Cited by 72
Deshors, P., Toulas, C., Arnauduc, F., Malric, L., Siegfried, A., Nicaise, Y., Lemarié, A., Larrieu, D., Tosolini, M., Moyal, E. C., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-2055-6 · Cited by 72
Self-citationCloughesy, T. F., Drappatz, J., de Groot, J., Prados, M. D., Reardon, D. A., Schiff, D., Chamberlain, M. C., Mikkelsen, T., Desjardins, A., Ping, J., et al. (2017) · Neuro-Oncology · doi:10.1093/neuonc/nox151 · Cited by 71
Bi-specific tenascin-C and fibronectin targeted peptide for solid tumor delivery
Lingasamy, P., Tobi, A., Haugas, M., Hunt, H., Paiste, P., Asser, T., Rätsep, T., Kotamraju, V. R., Bjerkvig, R., & Teesalu, T. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119373 · Cited by 69
Viotti, J., Duplan, E., Caillava, C., Condat, J., Goiran, T., Giordano, C., Marie, Y., Idbaih, A., Delattre, J.-Y., Honnorat, J., et al. (2014) · Oncogene · doi:10.1038/onc.2013.124 · Cited by 65
Self-citationTantillo, E., Vannini, E., Cerri, C., Spalletti, C., Colistra, A., Mazzanti, C. M., Costa, M., & Caleo, M. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104942 · Cited by 63
Induction of autophagy in temozolomide treated malignant gliomas
Natsumeda, M., Aoki, H., Miyahara, H., Yajima, N., Uzuka, T., Toyoshima, Y., Kakita, A., Takahashi, H., & Fujii, Y. (2011) · Neuropathology · doi:10.1111/j.1440-1789.2010.01197.x · Cited by 61
Identification of diverse tumor endothelial cell populations in malignant glioma
Carlson, J. C., Gutierrez, M. E. C., Lozzi, B., Huang-Hobbs, E., Turner, W. D., Tepe, B., Zhang, Y., Herman, A. M., Rao, G., Creighton, C. J., et al. (2020) · Neuro-Oncology · doi:10.1093/neuonc/noaa297 · Cited by 60
Karanam, N. K., & Story, M. D. (2020) · International Journal of Radiation Biology · doi:10.1080/09553002.2020.1837984 · Cited by 59
Navarro, A. G., Kmiecik, J., Leiss, L. W., Zelkowski, M., Engelsen, A. S. T., Bruserud, Ø., Zimmer, J., Enger, P. Ø., & Chekenya, M. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400859 · Cited by 58
Decoding Cancer Biology One Cell at a Time
Castro, L. N. G., Tirosh, I., & Suvà, M. L. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1376 · Cited by 58
Role of VAMP7-Dependent Secretion of Reticulon 3 in Neurite Growth
Wojnacki, J., Nola, S., Bun, P., Cholley, B., Filippini, F., Pressé, M. T., Lipecka, J., Lam, S. M., Nguyen, J., Simon, A., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108536 · Cited by 57
Self-citationKahn, S. A., Costa, S. L., Gholamin, S., Nitta, R. T., Dubois, L. G., Fève, M., Zeniou, M., Coelho, P. L. C., El-Habr, E. A., Cadusseau, J., et al. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201505421 · Cited by 56
Self-citationRosenthal, M. A., Curry, R. C., Reardon, D. A., Rasmussen, E., Upreti, V. V., Damore, M. A., Henary, H. A., Hill, J. S., & Cloughesy, T. F. (2019) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-019-03879-2 · Cited by 55
Characterization of glioblastoma in an orthotopic mouse model with magnetic resonance elastography
Schregel, K., Nazari, N., Nowicki, M. O., Palotai, M., Lawler, S. E., Sinkus, R., Barbone, P. E., & Patz, S. (2017) · NMR in Biomedicine · doi:10.1002/nbm.3840 · Cited by 54
Alternative Vascularization Mechanisms in Tumor Resistance to Therapy
Belotti, D., Pinessi, D., & Taraboletti, G. (2021) · Cancers · doi:10.3390/cancers13081912 · Cited by 54
Subventricular zones: new key targets for glioblastoma treatment
Khalifa, J., Tensaouti, F., Lusque, A., Plas, B., Lotterie, J.-A., Benouaich‐Amiel, A., Uro‐Coste, E., Lubrano, V., & Moyal, E. C. (2017) · Radiation Oncology · doi:10.1186/s13014-017-0791-2 · Cited by 51
Self-citationMa, S., Mangala, L. S., Hu, W. S., Bayaktar, E., Yokoi, A., Hu, W., Pradeep, S., Lee, S., Piehowski, P., Villar‐Prados, A., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109549 · Cited by 49
Mechanisms of Immunomodulation in Human Glioblastoma
Avril, T., Vauléon, É., Tanguy‐Royer, S., Mosser, J., & Quillien, V. (2011) · Immunotherapy · doi:10.2217/imt.11.39 · Cited by 47
Self-citationTargeting the perivascular niche in brain tumors
Seano, G. (2017) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000417 · Cited by 46
Self-citationTchoghandjian, A., Baeza, N., Béclin, C., Métellus, P., Colin, C., Ducray, F., Adélaïde, J., Rougon, G., & Figarella‐Branger, D. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-011-2093-5 · Cited by 45
Self-citationA new glioblastoma cell trap for implantation after surgical resection
Autier, L., Clavreul, A., Cacicedo, M. L., Franconi, F., Sindji, L., Rousseau, A., Perrot, R., Montero‐Menei, C. N., Castro, G. R., & Meneï, P. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.11.027 · Cited by 45
Self-citationAlmairac, F., Turchi, L., Sakakini, N., Debruyne, D. N., Elkeurti, S., Gjernes, E., Polo, B., Bianchini, L., Fontaine, D., Paquis, P., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-0855 · Cited by 42
Self-citationLee, E. Q., Zhang, P., Wen, P. Y., Gerstner, E. R., Reardon, D. A., Aldape, K., DeGroot, J. F., Pan, E., Raizer, J. J., Kim, L. J., et al. (2020) · Cancer · doi:10.1002/cncr.32811 · Cited by 41
SNAP25 Inhibits Glioma Progression by Regulating Synapse Plasticity via GLS-Mediated Glutaminolysis
Huang, Q., Lian, C., Dong, Y., Zeng, H., Liu, B., Xu, N., He, Z., & Guo, H. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.698835 · Cited by 41
Otvos, B., Alban, T. J., Grabowski, M. M., Bayık, D., Mulkearns-Hubert, E. E., Radivoyevitch, T., Rabljenovic, A., Johnson, S., Androjna, C., Mohammadi, A. M., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-3262 · Cited by 38
Targeting cancer's metabolic co-dependencies: A landscape shaped by genotype and tissue context
Bi, J., Wu, S., Zhang, W., & Mischel, P. S. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.05.002 · Cited by 37
Reversing the Tumor Target: Establishment of a Tumor Trap
Najberg, M., Mansor, M. H., Boury, F., Alvarez‐Lorenzo, C., & Garcion, E. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00887 · Cited by 36
Vascular Transdifferentiation in the CNS: A Focus on Neural and Glioblastoma Stem‐Like Cells
Guelfi, S., Duffau, H., Bauchet, L., Rothhut, B., & Hugnot, J. (2016) · Stem Cells International · doi:10.1155/2016/2759403 · Cited by 35
Self-citationLiu, L., An, D., Xu, J., Shao, B., Li, X., & Shi, J. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00076 · Cited by 35
Predicting Confined 1D Cell Migration from Parameters Calibrated to a 2D Motor-Clutch Model
Prahl, L. S., Stanslaski, M. R., Vargas, P., Piel, M., & Odde, D. J. (2020) · Biophysical Journal · doi:10.1016/j.bpj.2020.01.048 · Cited by 30
Pibuel, M. A., Poodts, D., Díaz, M., Molinari, Y. A., Franco, P. G., Hajos, S. E., & Lompardía, S. L. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00672-0 · Cited by 30
Targeting Glioblastoma Using a Novel Peptide Specific to a Deglycosylated Isoform of Brevican
von Spreckelsen, N., Fadzen, C. M., Hartrampf, N., Ghotmi, Y., Wolfe, J. M., Dubey, S., Yang, B., Kijewski, M. F., Wang, S., Farquhar, C. E., et al. (2021) · Advanced Therapeutics · doi:10.1002/adtp.202000244 · Cited by 26
Clavreul, A., Etcheverry, A., Tétaud, C., Rousseau, A., Avril, T., Henry, C., Mosser, J., & Meneï, P. (2014) · Journal of Neuro-Oncology · doi:10.1007/s11060-014-1683-z · Cited by 25
Self-citationInterstitial chemotherapy with mitoxantrone in recurrent malignant glioma: preliminary data
Boiardi, A., Salmaggi, A., Pozzi, A., Broggi, G., & Silvani, A. (1996) · Journal of Neuro-Oncology · doi:10.1007/bf00177479 · Cited by 24
Glioma Cell Secretion: A Driver of Tumor Progression and a Potential Therapeutic Target
Bonnin, D. A. A., Havrda, M. C., & Israel, M. A. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0345 · Cited by 24
Structural and molecular bases to IRE1 activity modulation
Langlais, T., Pelizzari‐Raymundo, D., Mahdizadeh, S. J., Gouault, N., Carreaux, F., Chevet, É., Eriksson, L. A., & Guillory, X. (2021) · Biochemical Journal · doi:10.1042/bcj20200919 · Cited by 24
Clarke, K., Daubon, T., Turan, N., Soulet, F., Zahari, M. M., Ryan, K. R., Durant, S., He, S., Herbert, J. M. J., Ankers, J., et al. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005325 · Cited by 22
Self-citationClavreul, A., Masouleh, M. P., Roger, E., & Meneï, P. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s194858 · Cited by 22
Self-citationRouland, L., Duplan, E., dos Santos, L. R., Bernardin, A., Katula, K. S., Manfioletti, G., Idbaïh, A., Checler, F., & da Costa, C. A. (2021) · Theranostics · doi:10.7150/thno.57549 · Cited by 17
Cho, C., Farquhar, C. E., Fadzen, C. M., Scott, B., Zhuang, P., von Spreckelsen, N., Loas, A., Hartrampf, N., Pentelute, B. L., & Lawler, S. E. (2022) · Cancers · doi:10.3390/cancers14092207 · Cited by 17
Wirsching, H., Silginer, M., Ventura, E., Macnair, W., Burghardt, I., Claassen, M., Gatti, S., Wichmann, J., Riemer, C., Schneider, H., et al. (2020) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2020.12.009 · Cited by 15
Taghipour, M., Omidvar, A., Razmkhah, M., Ghaderi, A. A., & Mojtahedi, Z. (2017) · PubMed Central · doi:10.22074/cellj.2016.4179 · Cited by 12
Mapping the tumor-infiltrating immune cells during glioblastoma progression
Lakshmanachetty, S., & Mitra, S. S. (2022) · Nature Immunology · doi:10.1038/s41590-022-01223-0 · Cited by 12
Early glioma is associated with abnormal electrical events in cortical cultures
Savarraj, J. P. J., Kelly, K. C., & DeCoster, M. A. (2019) · Medical & Biological Engineering & Computing · doi:10.1007/s11517-019-01980-5 · Cited by 6
Cited by
Current advance of nanotechnology in diagnosis and treatment for malignant tumors
Wang, B., Hu, S., Teng, Y., Chen, J., Wang, H., Xu, Y., Wang, K., Xu, J., Cheng, Y., & Gao, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01889-y · Cited by 558
Lin, H., Liu, C., Hu, A., Zhang, D., Yang, H., & Mao, Y. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01544-7 · Cited by 392
Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets
Guan, F., Wang, R., Yi, Z., Luo, P., Liu, W., Xie, Y., Liu, Z., Xia, Z., Zhang, H., & Cheng, Q. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02124-y · Cited by 371
Brown, C. E., Hibbard, J. C., Alizadeh, D., Blanchard, M. S., Natri, H. M., Wang, D., Ostberg, J. R., Aguilar, B., Wagner, J. R., Paul, J. A., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-02875-1 · Cited by 345
Immunotherapy for glioblastoma: current state, challenges, and future perspectives
Liu, Y., Zhou, F., Ali, H., Lathia, J. D., & Chen, P. (2024) · Cellular & Molecular Immunology · doi:10.1038/s41423-024-01226-x · Cited by 336
Metadata
- Authors
- Bikfalvi, A., da Costa, C. A., Avril, T., Barnier, J.-V., Bauchet, L., Brisson, L., Cartron, P. F., Castel, H., Chevet, E., Chneiweiss, H., Clavreul, A., Constantin, B., Coronas, V., Daubon, T., Dontenwill, M., Ducray, F., Entz-Werlé, N., Figarella-Branger, D., Fournier, I., Frenel, J.-S., Gabut, M., Galli, T., Gavard, J., Huberfeld, G., Hugnot, J.-P., Idbaih, A., Junier, M.-P., Mathivet, T., Menei, P., Meyronet, D., Mirjolet, C., Morin, F., Mosser, J., Moyal, E. C.-J., Rousseau, V., Salzet, M., Sanson, M., Seano, G., Tabouret, E., Tchoghandjian, A., Turchi, L., Vallette, F. M., Vats, S., Verreault, M., & Virolle, T.
- Venue
- Trends in Cancer
- Publisher
- Elsevier BV
- Published
- 2023-01
- Volume
- 9
- Issue
- 1
- Pages
- 9-27
- ISSN
- 2405-8025 (ISSN-L)
- 2405-8033
- OpenAlex
- W4309331387
- Cited by
- 302
- References
- 172
- FWCI
- 16.38
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.